RNAi-mediated suppression of ATP7B enhanced the sensitivity of resistant ovarian cancer cells to cisplatin and promoted the ability of cisplatin to reduce the growth of tumor engrafts in nude mice [105]. The gene discussed is ATP7B; the disease is ovarian carcinoma.